EuroMedica
AANP

Click Here for the Latest Episode of the Vitamin Professor Podcast Hosted by Gene Bruno

CBD


CBDistillery and Releaf App Partner to Study Efficacy of CBD and CBN in Addressing Stress and Sleep Issues, Seeking Volunteers

by Shari Barbanel | May 12, 2021

In partnership, CBDistillery (Denver, CO) and Releaf App have announced that they are recruiting 1,000 volunteers to conduct two studies to evaluate the efficacy of hemp-derived cannabidiol (CBD) and cannabinol (CBN) in assisting participants with their stress and sleep, as potential alternatives to over-the-counter and prescription medicines. CBDistillery will provide participants, at no cost in the stress study, ...

FDA Warns Selling of Topical CBD Products Violates FD&C Act

by Shari Barbanel | March 29, 2021

On March 22, the U.S. Food and Drug Administration (FDA) stated that it has issued warning letters to two companies for selling topical pain relief products labeled as containing cannabidiol (CBD) in ways that violate the Federal Food, Drug and Cosmetic Act (FD&C Act). Specifically, the warning letters addressed the illegal marketing of unapproved drugs ...

The Trifecta for Health

by Amber Lynn Vitale | March 23, 2021

In a world where there are so many influences upon our health, and so many diets to perfect our health, and so many supplements to promise us health, many of our patients and clients really just want to know, “Where should I invest the most time, money or effort?” I understand. The amount of information ...

FDA Withdraws Draft Guidance on CBD Enforcement Policy

by Shari Barbanel | February 1, 2021

After the Biden administration released a memo on Jan. 20 to all federal agencies informing them of a “regulatory freeze pending review,” the U.S. Food and Drug Administration (FDA) withdrew its “Cannabidiol Enforcement Policy; Draft Guidance for Industry.” Before it was withdrawn, the guidance was at the Office of Management and Budget (OMB) awaiting review. In ...

Pepper Oil Extract/Beta-Caryophyllene: A Non-cannabis Phytocannabinoid for Pain and Inflammation

If you live in the United States today, there is a good chance that you’ve heard of phytocannabinoids—at least THC and CBD. If you are part of the dietary supplement/natural products industry, it would be near impossible for you not to have heard of phytocannabinoids. Likewise, you almost certainly have heard the myriad claims being ...

The Endocannabinoid System & Phytocannabinoids

The popularity of CBD, or cannabidiol, has exploded and CBD sales are rapidly growing year after year. In fact, a report from the Brightfield Group predicts that the CBD market will hit $22 billion by 2022. Whether or not this turns out to be an exaggeration, there is no question about the unprecedented growth of ...

The Buzz on CBD

by Hilary Daninhirsch | November 3, 2020

CBD is riding a popularity wave but practitioners and consumers should take care to source from high-quality manufacturers exclusively. CBD is one of the fastest growing ingredients in the natural products world. CBD is the acronym for cannabidiol and is a compound found in the marijuana plant, cannabis. The other main ingredient found in cannabis ...

Caring for Bones, Joints & Muscles

by Nicholas Saraceno | July 1, 2020

In an ever-changing world, prevention and maintenance are as important as ever. When people hear about joint inflammation, they often associate the term with arthritis, and understandably so. According the Centers for Disease Control and Prevention (CDC), 23 percent of all adults—more than 54 million Americans—have arthritis. Approximately 24 million of those adults find themselves ...

MUIH Announces New Program in Cannabis Science

by Shari Barbanel | March 12, 2020

Maryland University of Integrative Health (MUIH) has announced that it has submitted a new program proposal to the Maryland Higher Education Commission (MHEC) for approval—the Post-Baccalaureate Certificate in Cannabis Science: Therapeutics, Product Design and Quality Assurance. The program examines the science behind cannabis and investigates the evidence for therapeutic benefits and risks, issues in product design ...

FDA Fails to Deliver Congressionally Mandated Report on CBD Regulations

by Shari Barbanel | February 26, 2020

The U.S. Food and Drug Administration (FDA) failed to meet its deadline to provide a Congressionally mandated report on how it plans to regulate CBD. Congress instructed the FDA in last year’s spending bill to adopt an enforcement discretion policy within 120 days and provide an update of its progress after 60 days. The agency’s first report ...

Don't Miss Out!

Sign up for Natural Practitioner Digital Newsletter
Digital Newsletter
Subscribe to Natural Practitioner Magazine
Natural Practitioner Magazine

Industry Professionals
Stay Informed!

Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Natural Practitioner magazine and digital newsletter.

Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.

Subscribe To Our Newsletter

Stay Informed! Breaking news, industry trends featured topics, and more.

Subscribe to our newsletter today!